Wird geladen...
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment. Most patients that undergo pharmacological inhibition with anti-VEGF agents need mu...
Gespeichert in:
| Veröffentlicht in: | Taiwan J Ophthalmol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer - Medknow
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947753/ https://ncbi.nlm.nih.gov/pubmed/31942427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_61_19 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|